Pathological Staging of pTaNxMx

Introduction to pTaNxMx Classification

The European Association of Urology recommends that the pTaNxMx classification be used to describe tumors that have been histologically evaluated, but where the regional lymph nodes and distant metastases cannot be assessed 1, 2
The prefix "p" in pTaNxMx indicates a pathological classification based on microscopic examination of the resected tissue, as opposed to a clinical evaluation 1, 3
This classification is typically applied to superficial tumors that do not invade the subepithelial connective tissue 1, 2

The pTa category represents a non-invasive papillary tumor confirmed by histopathological examination of the surgical specimen 1, 2
The Nx category means that the regional lymph nodes cannot be evaluated, which can occur when no lymph node dissection has been performed, or when the surgical specimen does not contain lymph nodes for pathological examination 1, 3, 4
The Mx category indicates that distant metastases cannot be evaluated, which can occur when appropriate imaging (CT, MRI, scintigraphy) has not been performed 1, 3, 4

The pTaNxMx classification is insufficient to determine the final stage of the disease and plan optimal treatment, according to the European Association of Urology 1, 3
Complete staging requires evaluation of all three components (T, N, M) to correctly stratify risk and guide therapeutic decisions 1, 3, 4
The absence of lymph node evaluation (Nx) prevents distinction between N0 (no lymph node metastases) and N+ (presence of lymph node metastases), which has major implications for survival and treatment 1, 2
In many cancers, 20-25% of patients who are clinically N0 may have occult lymph node metastases 1, 2

To optimize mortality and quality of life, complete staging including pathological lymph node evaluation and imaging for distant metastases must be performed, as recommended by the European Association of Urology 1, 3, 4
Lymph node evaluation may require surgical dissection, sentinel lymph node biopsy, or mediastinoscopy depending on the tumor location 1, 3
Thoraco-abdomino-pelvic CT imaging is generally required to exclude distant metastases 3, 4